表紙
市場調查報告書

臨床實驗室檢驗市場分析:各類型(CBC,HGB/HCT,BMP,BUN血肌酐,電極檢驗,HbA1c檢驗,綜合新陳代謝檢查,肝臟檢驗,腎臟檢驗,脂質檢驗),各最終用途,及市場區隔預測

Clinical Laboratory Tests Market Analysis Report By Type (CBC, HGB/HCT, BMP, HbA1c Testing, Electrolyte Testing, Liver Panel), By End Use (Primary Clinics, Central Labs), And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 421217
出版日期 內容資訊 英文 120 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
臨床實驗室檢驗市場分析:各類型(CBC,HGB/HCT,BMP,BUN血肌酐,電極檢驗,HbA1c檢驗,綜合新陳代謝檢查,肝臟檢驗,腎臟檢驗,脂質檢驗),各最終用途,及市場區隔預測 Clinical Laboratory Tests Market Analysis Report By Type (CBC, HGB/HCT, BMP, HbA1c Testing, Electrolyte Testing, Liver Panel), By End Use (Primary Clinics, Central Labs), And Segment Forecasts, 2019 - 2026
出版日期: 2019年02月28日內容資訊: 英文 120 Pages
簡介

本報告提供全球臨床實驗室檢驗市場相關調查,彙整市場趨勢,各類型,各用途,各最終用途,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
    • 促進要素分析
    • 阻礙要素分析
  • 滲透·成長預測製圖
  • SWOT分析
  • 產業分析:波特五力分析

第4章 各類型預測·趨勢分析

  • 各類型趨勢分析
  • 血液常規檢查
  • HGB/HCT檢驗
  • 基本新陳代謝檢查
  • BUN血肌酐檢驗
  • 電極檢驗
  • HbA1c檢驗
  • 綜合新陳代謝檢查
  • 肝臟檢驗
  • 腎臟檢驗
  • 脂質檢驗

第5章 各最終用途市場預測·趨勢分析

  • 各最終用途趨勢分析
  • 基層醫療
  • 中央檢驗室

第6章 各地區預測·趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • 策略架構
  • 市場進入分類
  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 978-1-68038-361-4

The global clinical laboratory tests market size is expected to reach USD 286.7 billion by 2026 at a 7.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Introduction of novel solutions for maximizing efficiency and minimizing errors is expected to boost the market.

Presence of favorable reimbursement policies is anticipated to positively influence the global market. According to an article published in the American Clinical Laboratory Association, clinical laboratory tests are reimbursed by Medicare beneficiaries either under the Clinical Laboratory Fee Schedule or Physician Fee Schedule depending on the nature of service.

Rising demand for early detection is anticipated to propel the market over the forecast period. Introduction of accurate and technologically advanced products such as biochips, companion diagnostics, and microarrays has resulted in growing demand for early detection of diseases. For instance, biochips are used for preparing thousands of RNA, DNA, or protein samples that can be processed on a single chip at the same time.

Presence of key players such as Laboratory Corporation of America Holdings, Qiagen, Quest Diagnostics Incorporated, Siemens Healthcare GmbH, and Abbott are anticipated to spur market growth. These industry participants are involved in strategic collaborations, product development, and regional expansion.

For instance, in 2017, Abbott's Alinity hq analyzer, generally used for hematology, received the CE Mark and is available across Europe, along with other countries that recognize the CE Mark to address productivity needs of high-volume laboratories.

In October 2018, NeoGenomics Laboratories Inc. entered into a strategic alliance with Pharmaceutical Product Development, LLC, a global contract research organization, to provide fully integrated pathology and molecular testing solutions to their PPD's pharmaceutical and biotech clients.

Further key findings from the report suggest:

  • The global clinical laboratory tests market is anticipated to reach USD 286.7 billion by 2026, expanding at a CAGR of 7.1% during the forecast period
  • By type, the basic metabolic panel segment held the largest share in 2018 mainly due to growing prevalence of lifestyle-induced diseases such metabolic abnormalities
  • Lipid panel tests is anticipated to be the fastest growing segment owing to increasing incidence of cardiovascular disorders. Hepatitis is estimated to account for the largest share in this segment, with liver cirrhosis exhibiting the fastest growth
  • By end use, central laboratories dominated the overall market due to presence of key laboratories such as Q2Solutions and Pharmaceutical Product Development, LLC. Primary clinics are projected to register the highest CAGR of 7.6% through 2026
  • North America was the largest regional market in 2018 owing to increasing geriatric population and high disease prevalence in this region. Asia Pacific, on the other hand, is anticipated to be the fastest growing region due to improving healthcare infrastructure

Some of the key companies are: OPKO Health, Inc.; Sonic Healthcare; Neogenomics Laboratories Inc.; Healthscope; Labco; Laboratory Corporation of America Holdings; Qiagen; Quest Diagnostics Incorporated; Siemens Healthcare Private Limited; Fresenius Medical Care AG & Co. KGaA; Merck KgaA; Tulip Diagnostics Ltd.; Bioscientia Institute for Medical Diagnostics GmbH; and Abbott.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market segmentation & scope
  • 1.2. Market definition
  • 1.3. Information procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources & third-party perspectives
    • 1.3.4. Primary research
  • 1.4. Information analysis
    • 1.4.1. Data analysis models
  • 1.5. Market formulation & data visualization
  • 1.6. Data validation & publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Clinical Laboratory Tests Market Variables, Trends & Scope

  • 3.1. Clinical Laboratory Tests Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Cost Structure Analysis
  • 3.4. Reimbursement Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Driver Analysis
      • 3.5.1.1. Rising geriatric population base
      • 3.5.1.2. Growing prevalence of target diseases
      • 3.5.1.3. Introduction of innovative solutions
      • 3.5.1.4. Rising demand for early disease detection
    • 3.5.2. Market Restraint Analysis
      • 3.5.2.1. Presence of ambiguous regulatory framework
  • 3.6. Clinical Laboratory Tests Market Analysis Tools
    • 3.6.1. Industry Analysis - Porter's
      • 3.6.1.1. Supplier Power: Moderate due to large number of diagnostic test manufacturers
      • 3.6.1.2. Buyer Power: Moderate due to presence of players entering into long-term contract
      • 3.6.1.3. Substitution Threat: Low due to no/less external substitutes
      • 3.6.1.4. Threat from new entrant: Moderate due to brand recognition of the existing players
      • 3.6.1.5. Competitive rivalry: High due to increasing mergers & acquisitions by major players
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Environmental Landscape
    • 3.7.3. Social Landscape
    • 3.7.4. Technology Landscape
    • 3.7.5. Legal Landscape
  • 3.8. Major Deals & Strategic Alliances Analysis
    • 3.8.1. Joint Ventures
    • 3.8.2. Mergers & Acquisitions
    • 3.8.3. Licensing & Partnership
    • 3.8.4. Technology Collaborations
    • 3.8.5. Strategic Divestments

Chapter 4. Clinical Laboratory Tests Market - Competitive Analysis

  • 4.1. Recent developments & impact analysis, by key market participants
  • 4.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
  • 4.3. Public Companies
    • 4.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
    • 4.3.2. Company Market Share/Ranking, by region
    • 4.3.3. Competitive Dashboard Analysis
    • 4.3.4. Market Differentiators
    • 4.3.5. Synergy Analysis: Major Deals & Strategic Alliances
  • 4.4. Private Companies
    • 4.4.1. List of key emerging companies
    • 4.4.2. Regional network map
    • 4.4.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)

Chapter 5. Clinical Laboratory Tests Market: Type Estimates & Trend Analysis

  • 5.1. Definitions & Scope
  • 5.2. Type market share analysis, 2018 & 2026
  • 5.3. Type Dashboard
  • 5.4. Global Clinical Laboratory Tests Market, by Type, 2013 to 2026
  • 5.5. Market Size & Forecasts and Trend Analyses, 2013 to 2026 for the following,
    • 5.5.1. Complete blood count
      • 5.5.1.1. Complete blood count market, 2014 - 2026 (USD Billion)
    • 5.5.2. HGB/HCT testing
      • 5.5.2.1. HGB/HCT testing market, 2014 - 2026 (USD Billion)
    • 5.5.3. Basic metabolic panel testing
      • 5.5.3.1. Basic metabolic panel market, 2014 - 2026 (USD Billion)
    • 5.5.4. BUN creatinine testing
      • 5.5.4.1. BUN creatinine testing market, 2014 - 2026 (USD Billion)
    • 5.5.5. Electrolytes testing
      • 5.5.5.1. Electrolytes testing market, 2014 - 2026 (USD Billion)
    • 5.5.6. HbA1c testing
      • 5.5.6.1. HbA1c testing market, 2014 - 2026 (USD Billion)
    • 5.5.7. Comprehensive metabolic panel testing
      • 5.5.7.1. Comprehensive metabolic panel testing market, 2014 - 2026 (USD Billion)
    • 5.5.8. Liver panel testing
      • 5.5.8.1. Liver panel testing market, 2014 - 2026 (USD Billion)
      • 5.5.8.2. Hepatitis
      • 5.5.8.2.1. Hepatitis market, 2014 - 2026 (USD Billion)
      • 5.5.8.3. Bile duct obstruction
      • 5.5.8.3.1. Bile duct obstruction market, 2014 - 2026 (USD Billion)
      • 5.5.8.4. Liver Cirrhosis
      • 5.5.8.4.1. Liver Cirrhosis market, 2014 - 2026 (USD Billion)
      • 5.5.8.5. Liver Cancer
      • 5.5.8.5.1. Liver Cancer market, 2014 - 2026 (USD Billion)
      • 5.5.8.6. Bone disease
      • 5.5.8.6.1. Bone disease market, 2014 - 2026 (USD Billion)
      • 5.5.8.7. Autoimmune disorders
      • 5.5.8.7.1. Autoimmune disorders market, 2014 - 2026 (USD Billion)
      • 5.5.8.8. Others
      • 5.5.8.8.1. Others market, 2014 - 2026 (USD Billion)
    • 5.5.9. Renal panel testing
      • 5.5.9.1. Renal panel testing market, 2014 - 2026 (USD Billion)
    • 5.5.10. Lipid panel testing
      • 5.5.10.1. Lipid panel testing market, 2014 - 2026 (USD Billion)

Chapter 6. Clinical Laboratory Tests Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions & Scope
  • 6.2. End-use market share analysis, 2018 & 2026
  • 6.3. End-use Dashboard
  • 6.4. Global Clinical Laboratory Tests Market, by End-use, 2013 to 2026
  • 6.5. Market Size & Forecasts and Trend Analyses, 2013 to 2026 for the following,
    • 6.5.1. Central Laboratories
      • 6.5.1.1. Central laboratories market, 2014 - 2026 (USD Billion)
      • 6.5.1.2. Complete blood count
      • 6.5.1.2.1. Complete blood count market, 2014 - 2026 (USD Billion)
      • 6.5.1.3. HGB/HCT testing
      • 6.5.1.3.1. HGB/HCT testing market, 2014 - 2026 (USD Billion)
      • 6.5.1.4. Basic metabolic panel testing
      • 6.5.1.4.1. Basic metabolic panel testing market, 2014 - 2026 (USD Billion)
      • 6.5.1.5. BUN creatinine testing.
      • 6.5.1.5.1. BUN creatinine testing. market, 2014 - 2026 (USD Billion)
      • 6.5.1.6. Electrolytes testing
      • 6.5.1.6.1. Electrolytes testing market, 2014 - 2026 (USD Billion)
      • 6.5.1.7. HbA1c testing
      • 6.5.1.7.1. HbA1c testing market, 2014 - 2026 (USD Billion)
      • 6.5.1.8. Comprehensive metabolic panel testing
      • 6.5.1.8.1. Comprehensive metabolic panel testing market, 2014 - 2026 (USD Billion)
      • 6.5.1.9. Liver panel testing
      • 6.5.1.9.1. Liver panel testing market, 2014 - 2026 (USD Billion)
      • 6.5.1.10. Renal panel testing
      • 6.5.1.10.1. Renal panel testing market, 2014 - 2026 (USD Billion)
      • 6.5.1.11. Lipid panel testing
      • 6.5.1.11.1. Lipid panel testing market, 2014 - 2026 (USD Billion)
    • 6.5.2. Primary Clinics
      • 6.5.2.1. Primary clinics market, 2014 - 2026 (USD Billion)
      • 6.5.2.2. Complete blood count
      • 6.5.2.3. Complete blood count market, 2014 - 2026 (USD Billion)
      • 6.5.2.4. HGB/HCT testing
      • 6.5.2.4.1. HGB/HCT testing market, 2014 - 2026 (USD Billion)
      • 6.5.2.5. Basic metabolic panel testing
      • 6.5.2.5.1. Basic metabolic panel testing market, 2014 - 2026 (USD Billion)
      • 6.5.2.6. BUN creatinine testing
      • 6.5.2.6.1. BUN creatinine testing market, 2014 - 2026 (USD Billion)
      • 6.5.2.7. Electrolytes testing
      • 6.5.2.7.1. Electrolytes testing market, 2014 - 2026 (USD Billion)
      • 6.5.2.8. HbA1c testing
      • 6.5.2.8.1. HbA1c testing market, 2014 - 2026 (USD Billion)
      • 6.5.2.9. Comprehensive metabolic panel testing
      • 6.5.2.9.1. Comprehensive metabolic panel testing market, 2014 - 2026 (USD Billion)
      • 6.5.2.10. Liver panel testing
      • 6.5.2.10.1. Liver panel testing market, 2014 - 2026 (USD Billion)
      • 6.5.2.11. Renal panel testing.
      • 6.5.2.11.1. Renal panel testing. market, 2014 - 2026 (USD Billion)
      • 6.5.2.12. Lipid panel testing
      • 6.5.2.12.1. Lipid panel testing market, 2014 - 2026 (USD Billion)

Chapter 7. Clinical Laboratory Tests Market: Regional Estimates & Trend analysis, by type, end-use and end-use by type

  • 7.1. Regional Market Snapshot
  • 7.2. Regional Market Share and Leading Players, 2018
    • 7.2.1. North America
    • 7.2.2. Europe
    • 7.2.3. Asia Pacific
    • 7.2.4. Latin America
    • 7.2.5. Middle East & Africa
  • 7.3. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. Middle East & Africa
  • 7.4. Market Size, & Forecasts, and Trend Analysis, 2018 to 2026
    • 7.4.1. North America
      • 7.4.1.1. North America clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.1.1.1. U.S.
      • 7.4.1.1.1.1. U.S. clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.1.1.2. Canada
      • 7.4.1.1.2.1. Canada clinical laboratory tests market, 2014 - 2026 (USD Billion)
    • 7.4.2. Europe
      • 7.4.2.1. Europe clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.2.1.1. U.K.
      • 7.4.2.1.1.1. U.K. clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.2.1.2. Germany
      • 7.4.2.1.2.1. Germany clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.2.1.3. Spain
      • 7.4.2.1.3.1. Spain clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.2.1.4. France
      • 7.4.2.1.4.1. France clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.2.1.5. Italy
      • 7.4.2.1.5.1. Italy clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.2.1.6. Russia
      • 7.4.2.1.6.1. Russia clinical laboratory tests market, 2014 - 2026 (USD Billion)
    • 7.4.3. Asia Pacific
      • 7.4.3.1. Asia Pacific clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.3.1.1. China
      • 7.4.3.1.1.1. China clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.3.1.2. Japan
      • 7.4.3.1.2.1. Japan clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.3.1.3. India
      • 7.4.3.1.3.1. India clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.3.1.4. South Korea
      • 7.4.3.1.4.1. South Korea clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.3.1.5. Singapore
      • 7.4.3.1.5.1. Singapore clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.3.1.6. Australia
      • 7.4.3.1.6.1. Australia clinical laboratory tests market, 2014 - 2026 (USD Billion)
    • 7.4.4. Latin America
      • 7.4.4.1. Latin America clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.4.1.1. Brazil
      • 7.4.4.1.1.1. Brazil clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.4.1.2. Mexico
      • 7.4.4.1.2.1. Mexico clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.4.1.3. Argentina
      • 7.4.4.1.3.1. Argentina clinical laboratory tests market, 2014 - 2026 (USD Billion)
    • 7.4.5. Middle East Africa
      • 7.4.5.1. MEA clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.5.1.1. South Africa
      • 7.4.5.1.1.1. South Africa clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.5.1.2. Saudi Arabia
      • 7.4.5.1.2.1. Saudi Arabia clinical laboratory tests market, 2014 - 2026 (USD Billion)
      • 7.4.5.1.3. U.A.E.
      • 7.4.5.1.3.1. U.A.E. clinical laboratory tests market, 2014 - 2026 (USD Billions)

Chapter 8. Company Profiles

  • 8.1. Strategic Framework
    • 8.1.1. Abbott
      • 8.1.1.1. Company overview
      • 8.1.1.2. Financial framework
      • 8.1.1.3. Product benchmarking
      • 8.1.1.4. Strategic initiatives
    • 8.1.2. ARUP Laboratories
      • 8.1.2.1. Company overview
      • 8.1.2.2. Financial framework
      • 8.1.2.3. Product benchmarking
      • 8.1.2.4. Strategic initiatives
    • 8.1.3. OPKO Health, Inc.
      • 8.1.3.1. Company overview
      • 8.1.3.2. Financial framework
      • 8.1.3.3. Product benchmarking
      • 8.1.3.4. Strategic initiatives
    • 8.1.4. Bioscientia Institut fur Medizinische Diagnostik GmbH
      • 8.1.4.1. Company overview
      • 8.1.4.2. Financial framework
      • 8.1.4.3. Product benchmarking
      • 8.1.4.4. Strategic initiatives
    • 8.1.5. Charles River
      • 8.1.5.1. Company overview
      • 8.1.5.2. Financial framework
      • 8.1.5.3. Product benchmarking
      • 8.1.5.4. Strategic initiatives
    • 8.1.6. NeoGenomics Laboratories, Inc.
      • 8.1.6.1. Company overview
      • 8.1.6.2. Financial framework
      • 8.1.6.3. Product benchmarking
      • 8.1.6.4. Strategic initiatives
    • 8.1.7. Genoptix, Inc.
      • 8.1.7.1. Company overview
      • 8.1.7.2. Financial framework
      • 8.1.7.3. Product benchmarking
      • 8.1.7.4. Strategic initiatives
    • 8.1.8. Healthscope
      • 8.1.8.1. Company overview
      • 8.1.8.2. Financial framework
      • 8.1.8.3. Product benchmarking
      • 8.1.8.4. Strategic initiatives
    • 8.1.9. Labco
      • 8.1.9.1. Company overview
      • 8.1.9.2. Financial framework
      • 8.1.9.3. Product benchmarking
      • 8.1.9.4. Strategic initiatives
    • 8.1.10. Laboratory Corporation of America Holdings (LabCorp)
      • 8.1.10.1. Company overview
      • 8.1.10.2. Financial framework
      • 8.1.10.3. Product benchmarking
      • 8.1.10.4. Strategic initiatives
    • 8.1.11. QIAGEN
      • 8.1.11.1. Company overview
      • 8.1.11.2. Financial framework
      • 8.1.11.3. Product benchmarking
      • 8.1.11.4. Strategic initiatives
    • 8.1.12. Quest Diagnostics
      • 8.1.12.1. Company overview
      • 8.1.12.2. Financial framework
      • 8.1.12.3. Product benchmarking
      • 8.1.12.4. Strategic initiatives
    • 8.1.13. Siemens Healthcare GmbH
      • 8.1.13.1. Company overview
      • 8.1.13.2. Financial framework
      • 8.1.13.3. Product benchmarking
      • 8.1.13.4. Strategic initiatives
    • 8.1.14. Sonic Healthcare
      • 8.1.14.1. Company overview
      • 8.1.14.2. Financial framework
      • 8.1.14.3. Product benchmarking
      • 8.1.14.4. Strategic initiatives
    • 8.1.15. Fresenius Medical Care Holdings, Inc.
      • 8.1.15.1. Company overview
      • 8.1.15.2. Financial framework
      • 8.1.15.3. Product benchmarking
      • 8.1.15.4. Strategic initiatives
    • 8.1.16. Merck KgaA
      • 8.1.16.1. Company overview
      • 8.1.16.2. Financial framework
      • 8.1.16.3. Product benchmarking
      • 8.1.16.4. Strategic initiatives
    • 8.1.17. Tulip Diagnostics (P) Ltd.
      • 8.1.17.1. Company overview
      • 8.1.17.2. Financial framework
      • 8.1.17.3. Product benchmarking
      • 8.1.17.4. Strategic initiatives
    • 8.1.18. Biosino Bio-technology and Science Inc
      • 8.1.18.1. Company overview
      • 8.1.18.2. Financial framework
      • 8.1.18.3. Product benchmarking
      • 8.1.18.4. Strategic initiatives

List of Tables

  • TABLE 1 List of Abbreviation
  • TABLE 2 North America Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 3 North America Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 4 North America Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 5 North America Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 6 U.S. Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 7 U.S. Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 8 U.S. Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 9 U.S. Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 10 Canada Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 11 Canada Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 12 Canada Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 13 Canada Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 14 Europe Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 15 Europe Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 16 Europe Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 17 Europe Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 18 U.K. Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 19 U.K. Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 20 U.K. Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 21 U.K. Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 22 Germany Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 23 Germany Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 24 Germany Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 25 Germany Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 26 France Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 27 France Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 28 France Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 29 France Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 30 Italy Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 31 Italy Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 32 Italy Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 33 Italy Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 34 Spain Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 35 Spain Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 36 Spain Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 37 Spain Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 38 Russia Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 39 Russia Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 40 Russia Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 41 Russia Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 42 Asia Pacific Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 43 Asia Pacific Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 44 Asia Pacific Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 45 Asia Pacific Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 46 Japan Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 47 Japan Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 48 Japan Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 49 Japan Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 50 China Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 51 China Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 52 China Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 53 China Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 54 India Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 55 India Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 56 India Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 57 India Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 58 Australia Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 59 Australia Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 60 Australia Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 61 Australia Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 62 South Korea Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 63 South Korea Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 64 South Korea Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 65 South Korea Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 66 Singapore Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 67 Singapore Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 68 Singapore Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 69 Singapore Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 70 Latin America Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 71 Latin America Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 72 Latin America Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 73 Latin America Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 74 Mexico Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 75 Mexico Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 76 Mexico Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 77 Mexico Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 78 Brazil Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 79 Brazil Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 80 Brazil Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 81 Brazil Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 82 Argentina Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 83 Argentina Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 84 Argentina Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 85 Argentina Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 86 MEA Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 87 MEA Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 88 MEA Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 89 MEA Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 90 South Africa Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 91 South Africa Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 92 South Africa Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 93 South Africa Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 94 U.A.E. Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 95 U.A.E. Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 96 U.A.E. Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 97 U.A.E. Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 98 Saudi Arabia Clinical Laboratory Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 99 Saudi Arabia Liver Panel Tests Market, by Type, 2013 - 2026 (USD Billion)
  • TABLE 100 Saudi Arabia Clinical Laboratory Tests Market, by End-use, 2013 - 2026 (USD Billion)
  • TABLE 101 Saudi Arabia Clinical Laboratory Tests End-use Market, by Type, 2013 - 2026 (USD Billion)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Market summary
  • FIG. 4 Market segmentation & scope
  • FIG. 5 Market size and growth prospects
  • FIG. 6 Global clinical laboratory tests - Key market driver analysis
  • FIG. 7 Global clinical laboratory tests market - Key market restraint analysis
  • FIG. 8 Penetration & growth prospect mapping
  • FIG. 9 Global clinical laboratory tests market - Porter's analysis
  • FIG. 10 Global clinical laboratory tests market - PESTEL analysis
  • FIG. 11 Global clinical laboratory tests market product outlook key takeaways
  • FIG. 12 Global clinical laboratory tests market: Type movement analysis
  • FIG. 13 Complete blood count market estimates, 2013 - 2026 (USD Billion)
  • FIG. 14 HGB/HCT tests market estimates, 2013 - 2026 (USD Billion)
  • FIG. 15 Basic metabolic panel market estimates, 2013 - 2026 (USD Billion)
  • FIG. 16 BUN creatinine tests market estimates, 2013 - 2026 (USD Billion)
  • FIG 17 Electrolytes testing market estimates, 2013 - 2026 (USD Billion)
  • FIG. 18 HbA1c tests market estimates, 2013 - 2026 (USD Billion)
  • FIG. 19 Comprehensive metabolic panel tests market estimates, 2013 - 2026 (USD Billion)
  • FIG. 20 Liver panel tests market estimates, 2013 - 2026 (USD Billion)
  • FIG. 21 Hepatitis market estimates, 2013 - 2026 (USD Billion)
  • FIG. 22 Bile duct obstruction market estimates, 2013 - 2026 (USD Billion)
  • FIG. 23 Liver Cirrhosis market estimates, 2013 - 2026 (USD Billion)
  • FIG. 24 Liver Cancer market estimates, 2013 - 2026 (USD Billion)
  • FIG. 25 Bone disease market estimates, 2013 - 2026 (USD Billion)
  • FIG. 26 Autoimmune disorder market estimates, 2013 - 2026 (USD Billion)
  • FIG. 27 Others market estimates, 2013 - 2026 (USD Billion)
  • FIG. 28 Renal panel tests market estimates, 2013 - 2026 (USD Billion)
  • FIG. 29 Lipid panel tests market estimates, 2013 - 2026 (USD Billion)
  • FIG. 30 Global clinical laboratory tests market end-use outlook key takeaways
  • FIG. 31 Global clinical laboratory tests market: End-use movement analysis
  • FIG. 32 Central laboratories market estimates, 2013 - 2026 (USD Billion)
  • FIG. 33 Primary clinics market estimates, 2013 - 2026 (USD Billion)
  • FIG. 34 Regional market place: Key takeaways
  • FIG. 35 Global clinical laboratory tests market: Regional movement analysis
  • FIG. 36 North America clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 37 U.S. clinical laboratory tests Market, 2013 - 2026 (USD Billion)
  • FIG. 38 Canada clinical laboratory tests Market, 2013 - 2026 (USD Billion)
  • FIG. 39 Europe clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 40 U.K. clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 41 Germany clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 42 France clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 43 Spain clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 44 Italy clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 45 Russia clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 46 Asia Pacific clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 47 Japan clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 48 China clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 49 India clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 50 South Korea clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 51 Singapore clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 52 Australia clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 53 Latin America clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 54 Brazil clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 55 Mexico clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 56 Argentina clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 57 MEA clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 58 South Africa clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 59 U.A.E. clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 60 Saudi Arabia clinical laboratory tests market, 2013 - 2026 (USD Billion)
  • FIG. 61 Strategy framework
Back to Top